These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37862194)

  • 1. Is GDNF to Parkinson's disease what BDNF is to Huntington's disease?
    Fusco FR; Paldino E
    Neural Regen Res; 2024 May; 19(5):973-974. PubMed ID: 37862194
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.
    Jahanshahi M; Brown RG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1169-77. PubMed ID: 8229028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free "GeneSwitch" vector.
    Cheng S; Tereshchenko J; Zimmer V; Vachey G; Pythoud C; Rey M; Liefhebber J; Raina A; Streit F; Mazur A; Bähr M; Konstantinova P; Déglon N; Kügler S
    Exp Neurol; 2018 Nov; 309():79-90. PubMed ID: 30076831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
    Schneider G; Oepen H; von Wedel HR
    Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis.
    Ishihara L; Oliveri D; Wild EJ
    Ann Clin Transl Neurol; 2021 Jan; 8(1):126-137. PubMed ID: 33217173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
    Alberch J; Pérez-Navarro E; Canals JM
    Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.
    Henderson T; Georgiou-Karistianis N; White O; Millist L; Williams DR; Churchyard A; Fielding J
    Mov Disord; 2011 Aug; 26(10):1893-9. PubMed ID: 21630355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials.
    Seiss E; Praamstra P; Hesse CW; Rickards H
    Exp Brain Res; 2003 Feb; 148(3):308-19. PubMed ID: 12541142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal CAG and CCG repeats in the Huntington's disease genes of Parkinson's disease patients.
    Rubinsztein DC; Leggo J; Goodburn S; Barton DE; Ferguson-Smith MA
    Am J Med Genet; 1995 Apr; 60(2):109-10. PubMed ID: 7485243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in nocturnal sleep in Huntington's and Parkinson's disease.
    Emser W; Brenner M; Stober T; Schimrigk K
    J Neurol; 1988 Jan; 235(3):177-9. PubMed ID: 2966851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment.
    Lin CY; Lin YC; Huang CY; Wu SR; Chen CM; Liu HL
    J Control Release; 2020 May; 321():519-528. PubMed ID: 32112852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
    Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of task-oriented training combined with aerobic training on serum BDNF, GDNF, IGF-1, VEGF, TNF-α, and IL-1β levels in people with Parkinson's disease: A randomized controlled study.
    Soke F; Kocer B; Fidan I; Keskinoglu P; Guclu-Gunduz A
    Exp Gerontol; 2021 Jul; 150():111384. PubMed ID: 33965556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
    Kuhl DE; Metter EJ; Riege WH; Markham CH
    Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.
    Pillon B; Deweer B; Agid Y; Dubois B
    Arch Neurol; 1993 Apr; 50(4):374-9. PubMed ID: 8460958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's.
    Illes J
    Brain Lang; 1989 Nov; 37(4):628-42. PubMed ID: 2479447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FINGERPRINT PATTERNS IN HUNTINGTON'S CHOREA AND PARKINSON'S DISEASE.
    BARBEAU A; TRUDEAU JG; COITEUX C
    Can Med Assoc J; 1965 Mar; 92(10):514-6. PubMed ID: 14275039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET.
    Boecker H; Ceballos-Baumann A; Bartenstein P; Weindl A; Siebner HR; Fassbender T; Munz F; Schwaiger M; Conrad B
    Brain; 1999 Sep; 122 ( Pt 9)():1651-65. PubMed ID: 10468505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.